CNQ · TRYP.CN
Tryp Therapeutics Inc.
CA$0.06CA$0.00 (0.0%)
Tryp Therapeutics Inc.: Healthcare · Biotechnology.
Loading market information…
CNQ · GTTX.CN · CAD
Stock price, earnings
Quote as of Jan 7, 2025, 04:43 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow GeneTether Therapeutics Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:22 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.06CA$0.00 (0.0%)
Tryp Therapeutics Inc.: Healthcare · Biotechnology.
CA$0.04+CA$0.01 (+33.33%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 74.19% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$5.93+$0.08 (+1.37%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
CA$0.10CA$0.00 (0.0%)
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.01$0.00 (0.0%)
MYND Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.0% below the high.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.
